Enhanced apoptosis of peripheral blood mononuclear cells in cardiac transplanted patients undergoing chronic immunosuppressive treatment

Transplant Immunology

Volumn 10, Issue 4, 2002, Pages 269-275

  Di Renzo, M ^a   Capecchi, P L ^a   Camurri, A ^b   Di Ciolla, F ^a   Maccherini, M ^a   Lisi, G ^a   Pompella, G ^a   Pasqui, A L ^a   Auteri, A ^a   Abbracchio, M P ^b   Laghi Pasini, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; Fas FasL; IL2; Transplantation

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE; DNA FRAGMENT; FAS ANTIBODY; FAS LIGAND; GLUCOCORTICOID; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; LIPOCORTIN 5; MESSENGER RNA; PHYTOHEMAGGLUTININ; FAS ANTIGEN; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; AGED; ALLOGRAFT; APOPTOSIS; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINESIS; GRAFT REJECTION; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MONONUCLEAR CELL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; T LYMPHOCYTE; BIOSYNTHESIS; DRUG EFFECT; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; CELL SURVIVAL; FAS LIGAND PROTEIN; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RNA, MESSENGER;

EID: 19044362547     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00075-8     Document Type: Article

References (32)

1. Wyllie AH. Apoptosis. Br J Cancer 199;67(2):205-208.
2. Abbas A. Die and let live: Eliminating dangerous lymphocytes. Cell 1996;84(5):655-657.
3. Mountz JD, Zhou T, Wu J, Wang W, Su X, Cheng J. Regulation of apoptosis in immune cells. J Clin Immunol 1995;15(1):1-16.
4. Zavazava N, Kabelitz D. Alloreactivity and apoptosis in graft rejection and transplantation tolerance. J Leuk Biol 2000;68(2):167-174.
5. Ferguson TA, Green DR. T cells are just dying to accept grafts. Nature Med 1999;5(11):1231-1232.
6. Wells DA, Li XC, Li Y, et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nature Med 1995;5(11):1303-1307.
7. Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nature Med 1999;5(11):1298-1302.
8. Allison AC. Immunosuppressive drugs: The first 50 years and a glance forward. Immunopharmacology 2000;47(2-3):63-83.
9. Tuosto L, Cundari E, Montani MS, Piccolella E. Analysis of susceptibility of mature human T-lymphocytes to dexamethasone-induced apoptosis. Eur J Immunol 1994;24(5):1061-1065.
10. Cohen JJ. Glucocorticoid-induced apoptosis in the thymus. Semin Immunol 1992;4(6):363-369.
11. Huss R, Hoy CA, Ottinger H, Grosse-Wilde H, Deeg HJ. Cyclosporine-induced apoptosis in CD4+ T lymphocytes and computer-simulated analysis: Modelling a treatment scenario for HIV infection. Res Immunol 1995;146(2):101-108.
12. Lanza L, Scudeletti M, Puppo F, et al. Prednisone increases apoptosis in in vitro activated human peripheral blood lymphocytes. Clin Exp Immunol 1996;103(3):482-490.
13. Scudeletti M, Lanza L, Monaco E, et al. Immune regulatory properties of corticosteroids: Prednisone induces apoptosis of human T lymphocytes following the CD3 down regulation. Ann NY Acad Sci 1999;876:164-179.
14. Shi YF, Sahai BM, Green DR. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 1989;339(6226):625-626.
15. Horigome A, Hirano T, Oka K, et al. Glucocorticoids and cyclosporine induce apoptosis in mitogen-activated human peripheral mononuclear cells. Immunopharmacology 1997;37(1):87-94.
16. Nagata S, Golstein P. The Fas death factor. Science 1995;267(5203):1449-1456.
17. Akbar AN, Borthwick NJ, Wickremasinghe RG, et al. Interleukin-2 receptor common gamma-chain signalling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xl) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 1996;26(2):294-299.
18. Kabawe Y, Ochi A. Programmed cell death and extrathymic reduction of Vβ8 + CD4 + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 1991;349(6306):245 - 248.
19. Li XC, Wells AD, Strom TB, Turka LA. The role of T cell apoptosis in transplantation tolerance. Curr Opin Immunol 2000;12(5):522-527.
20. Dai Z. Zoniecnzy BT, Baddour FK, Lakkis FG. Impaired alloantigen mediated T cell apoptosis and failure to induce long-term allograft survival in IL2 deficient mice. J Immunol 2000;12(5):522-527.
21. August C, Schmid KW, Dictl KW, Heidenreich S. Prognostic value of lymphocyte apoptosis in acute rejection of renal allografts. Transplantation 1999;67(4):581-585.
22. Lenardo MJ, Chan FMK. Hornung F, et al. Mature T lymphocyte apoptosis: Immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999;17:221-253.
23. Kabelitz D, Pohl T, Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 1993;14(7):338-339.
24. Owen-Schaub LB, Yonehara S. Crump WL, Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992;140(1):197-205.
25. Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O. Activation-induced cell death: Resistance or susceptibility correlate with cell surface Fas ligand expression and T helper phenotype. Cell Immunol 1997;181(1):93-100.
26. Kirsch AH, Mahmood AA, Andres J, et al. Apoptosis of human T-cells: Induction by glucocorticoids or surface receptor ligation in vitro and ex vivo. J Biol Regul Homeost Agents 1999; 13(2):80-89.
27. Resch K, Szamel M. Molecular mechanisms of the immunosuppressive action of cyclosporin A. Int J Immunopharmacol 1997;19(9-10):579-585.
28. Jannsen O, Sanzenbacher R, Kabelitz D. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res 2000;301(01):85-99.
29. Lorenz HM, Grunko M,Hyeronimus T. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune disease. Arthritis Rheum 1997;40(2):306-317.
30. Di Renzo M, Zhou Z, George I, Becker K. Cunningham-Rundles C. Enhanced apoptosis of T cells in common variable immunodeficiency: Role of defective CD28 costimulation. Clin Exp Immunol 2000;120(3):503-511.
31. Adachi Y, Oyaizu N, Than S, McCloskey TW, Pahwa S. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: Correlation with its ability to block culture-induced down-modulation of Bcl-2. J Immunol 1996;157(9):4184-4193.
32. Mor F, Cohen I.R. IL2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. J Immunol 1996;156(2):515-522.